Cannabis Bioscience International Holdings (CBIH) Stock Overview
Cannabis Bioscience International Holdings, Inc. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CBIH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Cannabis Bioscience International Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0003 |
| 52 Week High | US$0.0008 |
| 52 Week Low | US$0.0002 |
| Beta | 1.65 |
| 1 Month Change | -14.29% |
| 3 Month Change | -25.00% |
| 1 Year Change | -40.00% |
| 3 Year Change | -33.33% |
| 5 Year Change | -85.71% |
| Change since IPO | -98.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBIH | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 20.0% | 3.2% | 1.1% |
| 1Y | -40.0% | 8.3% | 28.7% |
Return vs Industry: CBIH underperformed the US Life Sciences industry which returned 8.3% over the past year.
Return vs Market: CBIH underperformed the US Market which returned 28.7% over the past year.
Price Volatility
| CBIH volatility | |
|---|---|
| CBIH Average Weekly Movement | 32.0% |
| Life Sciences Industry Average Movement | 8.1% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CBIH's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CBIH's weekly volatility (32%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 2 | Dante Picazo | n/a |
Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. It is also involved in clinical trials and medical research services through its Alpha Research Institute; and sale of CBD products.
Cannabis Bioscience International Holdings, Inc. Fundamentals Summary
| CBIH fundamental statistics | |
|---|---|
| Market cap | US$3.52m |
| Earnings (TTM) | -US$515.29k |
| Revenue (TTM) | US$123.63k |
Is CBIH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBIH income statement (TTM) | |
|---|---|
| Revenue | US$123.63k |
| Cost of Revenue | US$26.23k |
| Gross Profit | US$97.39k |
| Other Expenses | US$612.68k |
| Earnings | -US$515.29k |
Last Reported Earnings
Feb 28, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.000044 |
| Gross Margin | 78.78% |
| Net Profit Margin | -416.81% |
| Debt/Equity Ratio | -83.2% |
How did CBIH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/25 13:32 |
| End of Day Share Price | 2026/05/22 00:00 |
| Earnings | 2026/02/28 |
| Annual Earnings | 2025/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cannabis Bioscience International Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.